IBEX (IBEX) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 May, 2026Executive summary
Achieved record quarterly revenue of $164.4 million, up 16.8% year-over-year, with double-digit growth in revenue, adjusted EBITDA, and EPS for multiple consecutive quarters, driven by Health Tech, Technology, Retail & E-commerce, and Travel, Transportation & Logistics, partially offset by declines in Telecommunications.
Diluted EPS rose 22% to $0.89, and adjusted EPS increased 11% to $0.91, with net income up 27.3% to $13.3 million.
Maintained 100% client retention for the quarter and 99.9% revenue retention for the year, with 11 new client wins through April.
Announced a strategic partnership with Sierra/Sierra.ai to integrate AI-powered CX solutions, accelerating deal wins and positioning as a leader in AI-powered BPO 3.0.
Growth attributed to expansion in higher margin offshore regions, new client wins, and increased digital acquisition business.
Financial highlights
Net income increased to $13.3 million from $10.5 million year-over-year; fully diluted EPS rose to $0.89 from $0.73.
Adjusted EBITDA reached $22.0 million (13.4% of revenue), up from $19.4 million (13.8%) year-over-year.
Free cash flow for the quarter was $6.6 million, up from $3.6 million year-over-year; for the nine months ended March 31, 2026, free cash flow was $9.5 million.
SG&A expenses decreased to 16.7% of revenue from 19.2% year-over-year.
Cash and cash equivalents as of March 31, 2026, were $15.4 million, with net cash of $14.0 million and total debt of $1.4 million.
Outlook and guidance
Fiscal year 2026 revenue guidance raised to $638–$642 million (previously $620–$630 million); adjusted EBITDA guidance increased to $82–$84 million (previously $80–$82 million).
CapEx guidance increased to $25–$30 million to support growth in higher-margin regions.
Management expects continued growth driven by expansion in offshore regions, digital solutions, and AI integration.
Expect DSOs to remain stable in the low to mid-70s; DSO improved to 71 days from 77 days year-over-year.
Macroeconomic factors such as inflation, interest rates, and global uncertainty may impact future results.
Latest events from IBEX
- Strong growth, high client retention, and AI-driven expansion define the company's outlook.IBEX
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Record revenue and EPS growth, raised FY2026 guidance, and strong digital and AI momentum.IBEX
Q2 20265 Feb 2026 - Record financials, margin expansion, and AI-driven growth set up for FY 2025.IBEX
Q4 202420 Jan 2026 - Record Q1 revenue, margin gains, and raised outlook driven by vertical growth and AI innovation.IBEX
Q1 202515 Jan 2026 - Record Q2 revenue, margin expansion, and raised FY25 guidance highlight strong growth momentum.IBEX
Q2 202511 Dec 2025 - Director nominee withdrawal prompts Board to address a new vacancy before the 2025 meeting.IBEX
Proxy Filing5 Dec 2025 - Board commits to simple majority for Bye-Laws changes, enhancing shareholder rights.IBEX
Proxy Filing1 Dec 2025 - Key votes on board, compensation, and auditor highlight governance and incentive plan updates.IBEX
Proxy Filing1 Dec 2025 - Shareholders will vote on board size, director elections, and auditor, with TRGI retaining control.IBEX
Proxy Filing1 Dec 2025